Pharmaceuticals News and Research

RSS

Researcher receives federal grant to advance study of tumor nanoimmunology

The five-year grant was awarded by the National Cancer Institute of the National Institutes of Health. The funds come on top of four previous grants to support Ljubimova's work. In all, the institute has awarded Ljubimova $16.5 million over the last five years.

29 Jun 2016

Scientists develop novel bionic cardiac patch to treat heart problems

Scientists and doctors in recent decades have made vast leaps in the treatment of cardiac problems - particularly with the development in recent years of so-called "cardiac patches," swaths of engineered heart tissue that can replace heart muscle damaged during a heart attack.

28 Jun 2016

Why does appetite loss occur during illness? An interview with Prof. Conti and Prof. Francesconi

Appetite, as a word, come from the Latin appetitus, meaning "desire for.” Therefore, appetite can be defined as a pleasurable sensation or the desire to eat. This sensation is coordinated by several brain areas associated with reward processing such amygdala, hippocampus, ventral pallidum, nucleus accumbens and striatum, and others.

28 Jun 2016

Researchers test new drug with potential to reverse or slow progression of asthma

A new drug with the potential to reverse or slow the development of asthma is being tested by researchers at The University of Queensland.

28 Jun 2016

Study highlights lack of guidance on deintensifying diabetic regimens

Patients with Type 2 diabetes often receive unnecessarily intensive treatment for long durations, increasing their risk of severe hypoglycaemia, research shows.

25 Jun 2016

Oncogene signatures could help design new drug treatments for breast cancer

Drug treatments for breast cancer patients might soon be designed based on the unique genetic autograph of their tumor.

25 Jun 2016

New Bruker In-Vivo Xtreme II system accelerates preclinical infectious disease research at University of Lausanne

Bruker’s recently introduced preclinical in vivo imaging system – In-Vivo Xtreme II™– is accelerating the preclinical research into infectious diseases being undertaken at the Institute of Microbiology at the University of Lausanne, Switzerland. Infectious diseases are the second leading cause of death worldwide.

From Bruker BioSpin Division 24 Jun 2016

Depression reduces COPD maintenance medication adherence in older adults

A recent study in the Annals of the American Thoracic Society found that in a nationally representative sample of Medicare beneficiaries who were newly diagnosed with COPD, adherence to maintenance medications decreased with new episodes of depression.

24 Jun 2016

African Americans perceive depression as weakness rather than health condition

Depression in African Americans, according to Sirry Alang, assistant professor of sociology and anthropology at Lehigh University, is expressed in ways that are inconsistent with symptoms of depression laid out in the Diagnostic and Statistical Manual of Mental Disorders.

23 Jun 2016

New light-based technology facilitates deeper look into human body

New light-based technologies that facilitate a look inside the human body using light -- and without cutting into the tissue -- promise to enable both compact, wearable devices for point-of-care diagnostics as well as powerful new systems that provide even more information and from even deeper under the skin.

23 Jun 2016

Study shows many people may have potential to develop Huntington's disease

More people may have the potential to develop Huntington's disease than previously thought, according to a study published in the June 22, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology.

23 Jun 2016

ACP provides physician perspective on rising prescription drug prices

The American College of Physicians today provided physician perspective on the escalating cost of prescription drugs, the impact of the costs on internal medicine physicians and their patients, and support for the intent of the bipartisan Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016 to reduce anti-competitive practices.

22 Jun 2016

New study reveals conversion of oral cannabidiol to THC by acidic fluids in the stomach

A new study demonstrating the conversion of oral cannabidiol (CBD) to the psychoactive component tetrahydrocannabinol (THC) in the presence of gastric fluids could explain why children given CBD to treat epilepsy had an unexpectedly high rate of adverse effects such as sleepiness and fatigue.

22 Jun 2016

New collaborative research program connects canine and human cancers

A new collaborative research program pairs oncologists who treat childhood and adult sarcomas with veterinarians who manage the same cancers in canine patients.

17 Jun 2016

METTLER TOLEDO declares availability of new on-demand free webinar on reaction calorimetry

METTLER TOLEDO has announced the availability of a new on-demand webinar - Reaction Calorimetry in the Chemical Process Industry.

From Mettler-Toledo International Inc. 16 Jun 2016

Complex 36-point therapeutic personalized program can help reverse memory loss in early AD patients

Results from quantitative MRI and neuropsychological testing show unprecedented improvements in ten patients with early Alzheimer's disease (AD) or its precursors following treatment with a programmatic and personalized therapy. Results from an approach dubbed metabolic enhancement for neurodegeneration are now available online in the journal Aging.

16 Jun 2016

TSRI scientists develop novel technique for finding drug candidates

Scientists at The Scripps Research Institute have developed a powerful new method for finding drug candidates that bind to specific proteins.

16 Jun 2016

Prospective biobank studies with genetic data can help improve drug development, reduce costs

With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?

15 Jun 2016

How can we defeat drug resistance? An interview with Dr Grania Brigden

The O’Neill report is a wide ranging report recognising anti-microbial resistance (AMR) as a global problem with major public health and economic significance.

15 Jun 2016

Clinical trial to test efficacy of new drug for chronic cough

The National Institute for Health Research has today announced its participation in a clinical trial to test a promising new treatment for chronic cough. If approved, this would be the first new cough drug in 50 years and offer hope to the millions of people living with chronic cough for whom few, if any, effective treatments exist.

14 Jun 2016